Cargando…

Identification of tipifarnib sensitivity biomarkers in T-cell acute lymphoblastic leukemia and T-cell lymphoma

Patients diagnosed with T-cell leukemias and T-cell lymphomas (TCLs) still have a poor prognosis and an inadequate response to current therapies, highlighting the need for targeted treatments. We have analyzed the potential therapeutic value of the farnesyltransferase inhibitor, tipifarnib, in 25 TC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alonso-Alonso, Ruth, Mondéjar, Rufino, Martínez, Nerea, García-Diaz, Nuria, Pérez, Cristina, Merino, David, Rodríguez, Marta, Esteve-Codina, Anna, Fuste, Berta, Gut, Marta, Burrows, Francis, Scholz, Catherine, Vaqué, Jose Pedro, Gualberto, Antonio, Piris, Miguel Ángel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174413/ https://www.ncbi.nlm.nih.gov/pubmed/32317694 http://dx.doi.org/10.1038/s41598-020-63434-5

Ejemplares similares

Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations
por: Ho, Alan L., et al.
Publicado: (2021)

Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines
por: Mondejar, Rufino, et al.
Publicado: (2017)

Tipifarnib in the treatment of acute myeloid leukemia
por: Thomas, Xavier, et al.
Publicado: (2007)

Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers
por: Rodríguez, Marta, et al.
Publicado: (2021)

Tipifarnib and tanespimycin show synergic proapoptotic activity in U937 cells
por: Krzykowska-Petitjean, Katarzyna, et al.
Publicado: (2011)

Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia
por: Karp, Judith E, et al.
Publicado: (2008)

Tipifarnib prevents development of hypoxia-induced pulmonary hypertension
por: Duluc, Lucie, et al.
Publicado: (2017)

FAS system deregulation in T-cell lymphoblastic lymphoma
por: Villa-Morales, M, et al.
Publicado: (2014)

Microarray analysis reveals genetic pathways modulated by tipifarnib in acute myeloid leukemia
por: Raponi, Mitch, et al.
Publicado: (2004)

A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors
por: DING, NING, et al.
Publicado: (2014)

Combination of Tipifarnib and Sunitinib Overcomes Renal Cell Carcinoma Resistance to Tyrosine Kinase Inhibitors via Tumor-Derived Exosome and T Cell Modulation
por: Greenberg, Jacob W., et al.
Publicado: (2022)

Targeting of CD34(+)CD38(-) cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia
por: Jawad, Mays, et al.
Publicado: (2012)

Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development
por: Roncero, A M, et al.
Publicado: (2016)

Small extracellular vesicles induce resistance to anti-GD2 immunotherapy unveiling tipifarnib as an adjunct to neuroblastoma immunotherapy
por: Liu, Xiaoming, et al.
Publicado: (2022)

Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
por: Cooper, Todd M
Publicado: (2007)

Genomic landscape of T-cell lymphoblastic lymphoma
por: Li, Zhaoming, et al.
Publicado: (2022)

Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia
por: Veltri, Giulia, et al.
Publicado: (2022)

An integrated prognostic model for diffuse large B‐cell lymphoma treated with immunochemotherapy
por: Rodríguez, Marta, et al.
Publicado: (2022)

Antitumor effects of low‐dose tipifarnib on the mTOR signaling pathway and reactive oxygen species production in HIF‐1α‐expressing gastric cancer cells
por: Egawa, Noriyuki, et al.
Publicado: (2021)

Tipifarnib Potentiates the Antitumor Effects of PI3Kα Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity
por: Smith, Alison E., et al.
Publicado: (2023)

Prognostic relevance of genetic variations in T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma
por: Yu, Hui, et al.
Publicado: (2019)

Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra®, R115777) in combination with gemcitabine and cisplatin in patients with advanced solid tumours
por: Siegel-Lakhai, W S, et al.
Publicado: (2005)

Correction: Colorectal Adenomas Contain Multiple Somatic Mutations That Do Not Coincide with Synchronous Adenocarcinoma Specimens
por: Vaqué, José P., et al.
Publicado: (2015)

Colorectal Adenomas Contain Multiple Somatic Mutations That Do Not Coincide with Synchronous Adenocarcinoma Specimens
por: Vaqué, José P., et al.
Publicado: (2015)

Clinical impact of miR-223 expression in pediatric T-Cell lymphoblastic lymphoma
por: Pomari, Elena, et al.
Publicado: (2017)

Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma
por: Li, Zhen, et al.
Publicado: (2023)

De Novo Assembly and Annotation of the Larval Transcriptome of Two Spadefoot Toads Widely Divergent in Developmental Rate
por: Liedtke, H. Christoph, et al.
Publicado: (2019)

Blastomeres of 8-cell mouse embryos differ in their ability to generate embryonic stem cells and produce lines with different transcriptional signatures
por: Alonso-Alonso, Sandra, et al.
Publicado: (2023)

Case series of precursor B-cell lymphoblastic lymphoma
por: Kim, Jin Yong, et al.
Publicado: (2014)

Primary pleural precursor B-Cell lymphoblastic lymphoma
por: Williams, Mark S, et al.
Publicado: (2015)

Immune Thrombocytopenia in a Child with T Cell Lymphoblastic Lymphoma
por: Tokeji, Kayo, et al.
Publicado: (2016)

Deregulated FADD expression and phosphorylation in T-cell lymphoblastic lymphoma
por: Marín-Rubio, José L., et al.
Publicado: (2016)

Extensive Pleural Involvement in Pediatric T-Cell Lymphoblastic Lymphoma
por: Jain, Bela, et al.
Publicado: (2022)

T-cell Lymphoblastic Lymphoma Presenting as a Pituitary Mass
por: Sreedhara, Padmini, et al.
Publicado: (2023)

Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma
por: González-Rincón, Julia, et al.
Publicado: (2019)

A Phase 1 Trial Dose Escalation Study of Tipifarnib on a Week-On, Week-Off Schedule in Relapsed, Refractory or High-Risk Myeloid Leukemia
por: Kirschbaum, Mark, et al.
Publicado: (2011)

Transformation of T-Cell Acute Lymphoblastic Lymphoma to Peripheral T-Cell Lymphoma: A Report of Two Cases
por: Markow, Michael, et al.
Publicado: (2018)

Abnormal Lymphoid Cells in T-Cell Acute Lymphoblastic Leukemia/Lymphoma Resembling Burkitt Lymphoma Morphology
por: Yu, Ying, et al.
Publicado: (2023)

PB2164: PROGNOSTIC IMPACT OF ONCOGENE DEK IN DIFFUSE LARGE B-CELL LYMPHOMA
por: Alonso Alonso, R., et al.
Publicado: (2022)

Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma
por: Pedrosa, Lucía, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_puofllhp1kotpbr0qug92lhiqg